A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

Careful analysis of the seemingly intractable problem of rising medical costs can typically be reduced to three things: 1) ...

A judge on Tuesday rejected a challenge from major pharmaceutical companies against Washington’s new law trying to reduce ...

Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in ...

Amid barbs over the shutdown and broader healthcare funding cuts, a Thursday committee hearing brought bipartisan agreement that more can be done to ensure the pricey drug subsidy program remains a ...

Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics.

WASHINGTON: The U.S. Department of Health and Human Services building is shown in Washington, DC. (Photo by Mark Wilson/Getty Images) In 1992, Congress created the 340B Drug Pricing Program to provide ...

The 340B program was originally designed to assist hospitals that treat under- or uninsured patients in receiving discounted pharmaceutical drugs. Now, the federal subsidy program is getting a second ...

The acquisition will expand Model N’s capabilities as a leading revenue management platform for life sciences manufacturers and extend its 340B offerings to better serve customers. 340B, a federal ...

The Health Resources and Services Administration ("HRSA") plans to implement a limited pilot program that will allow approved manufacturers to issue post-purchase rebates for 340B covered outpatient ...